Ebrahim Variava to Cohort Studies
This is a "connection" page, showing publications Ebrahim Variava has written about Cohort Studies.
Connection Strength
0,264
-
Evolving therapies for rifampicin-resistant tuberculosis: balancing efficacy and toxicity. Lancet Respir Med. 2020 04; 8(4):326-328.
Score: 0,139
-
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosing. BMC Infect Dis. 2021 Jan 04; 21(1):5.
Score: 0,037
-
Hospitalization and post-discharge care in South Africa: A critical event in the continuum of care. PLoS One. 2018; 13(12):e0208429.
Score: 0,032
-
Influenza Viral Shedding in a Prospective Cohort of HIV-Infected and Uninfected Children and Adults in 2 Provinces of South Africa, 2012-2014. J Infect Dis. 2018 09 08; 218(8):1228-1237.
Score: 0,031
-
Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. Int J Tuberc Lung Dis. 2015 Aug; 19(8):979-85.
Score: 0,025